Plasmodium coatneyi-infected erythrocytes bind to C32 amelanotic melanoma cells under static and flow conditions

Satoru Kawai1, Masahiro Yoshinari, Jun Matsumoto

  • 1Department of Tropical Medicine and Parasitology, Dokkyo University School of Medicine, Tochigi, Japan.

Insights

Plasmodium coatneyi-infected red blood cells bind to melanoma cells, with CD36 identified as a key adhesion receptor. This interaction was observed under both static and physiological flow conditions, highlighting its biological significance.

Area of Science:

  • Immunology
  • Cell Biology
  • Parasitology

Background:

  • Plasmodium coatneyi infection in Japanese macaques causes severe disease.
  • Understanding the mechanisms of infected red blood cell adhesion is crucial for disease pathogenesis.

Purpose of the Study:

  • To investigate the binding of Plasmodium coatneyi-infected red blood cells (IRBCs) to C32 amelanotic melanoma cells.
  • To identify the specific adhesion molecules involved in this interaction.

Main Methods:

  • Static and physiological flow adhesion assays using IRBCs and C32 cells.
  • Immunofluorescence staining with anti-CD36 monoclonal antibody (mAb).
  • Inhibition assays using anti-CD36 and anti-ICAM-1 mAbs.

Main Results:

  • IRBCs demonstrated binding to C32 cells under static conditions.
  • Adhesion and rolling of IRBCs on C32 cells were observed under physiological flow.
  • Anti-CD36 mAb significantly inhibited IRBC adhesion and rolling (75-100%).
  • Anti-ICAM-1 mAb showed partial inhibition (20-40%).

Conclusions:

  • CD36 is a principal adhesion receptor for Plasmodium coatneyi-infected erythrocytes.
  • CD36-mediated adhesion plays a significant role in the interaction between IRBCs and melanoma cells.